Item 1. Security and Issuer.
This Statement relates to shares of common stock, par value $0.01 per share (the “Common Stock”), of Fluor Corporation, a Delaware corporation (the “Issuer”). The Issuer’s principal executive offices are located at 6700 Las Colinas Boulevard Irving, Texas 75039.
This Amendment No. 2 (“Amendment No. 2”) amends and supplements the Schedule 13D filed September 11, 2019 (the “Original Statement”) filed by the Reporting Persons on September 11, 2019, as amended by that certain Amendment No. 1 to the Original Statement, filed by the Reporting Persons on March 16, 2020 and as amended through this Amendment No. 2 (the “Statement”).
Except as specifically provided herein, this Amendment No. 2 does not modify any of the information previously reported on the Statement. Capitalized terms used but not otherwise defined in this Amendment No. 2 shall have the meanings ascribed to them in the Statement. The filing of this Amendment No. 2 shall not be construed to be an admission by the Reporting Persons that a material change has occurred in the facts set forth in the Original Statement or that this Amendment No. 2 is required under Rule13d-2 of the Securities Exchange Act.
Item 2. Identity and Background.
No Change.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 of the Statement shall be amended and restated as follows:
The shares of Common Stock reported to be beneficially owned by the Reporting Persons were acquired in the open market. All such purchases of Common Stock were funded by investment capital, which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business. The amount of funds expended for such purchases by the Reporting Persons to this date is $167,714,970, including commissions and other execution-related costs.
Item 4. Purpose of Transaction.
No Change.
Item 5. Interest in Securities of the Issuer.
(a)-(b) As of the date of this Amendment No. 2, (i)ISICO-A may be deemed to be the beneficial owner of 4,783,687 shares of Common Stock, which represents 3.41% of the total number of shares of Common Stock outstanding, (ii) ISICO may be deemed to be the beneficial owner of 7,320,191 shares of Common Stock, which represents 5.22% of the total number of shares of Common Stock outstanding, (iii) BCP FundII-A may be deemed to be the beneficial owner of 4,783,687 shares of Common Stock, which represents 3.41% of the total number of shares of Common Stock outstanding, (iv) BCP Fund II may be deemed to be the beneficial owner of 7,320,191 shares of Common Stock, which represents 5.22% of the total number of shares of Common Stock outstanding, (v) BCP Fund GP II may be deemed to be the beneficial owner of 12,103,878 shares of Common Stock, which represents 8.63% of the total number of shares of Common Stock outstanding, (vi) BCP Fund UGP may be deemed to be the beneficial owner of 12,103,878 shares of Common Stock, which represents 8.63% of the total number of shares of Common Stock outstanding, (vii) Mr. Jenkins may be deemed to be the beneficial owner of 12,103,878 shares of Common Stock, which represents 8.63% of the total number of shares of Common Stock outstanding and (viii) Mr. Bernhard may be deemed to beneficially own 12,158,338 shares of Common Stock, which represents 8.67% of the total number of shares of Common Stock outstanding, 54,460 of which he may be deemed to beneficially own on an individual basis.
BCP Fund UGP is managed by James M. Bernhard Jr. and Jeffrey Scott Jenkins. BCP Fund UGP is the sole general partner of BCP Fund GP II, which is the sole general partner of both BCP Fund II and BCP FundII-A. BCP Fund II has dispositive voting power over ISICO, and BCP FundII-A has dispositive voting power overISICO-A.